| scholarly article | Q13442814 |
| P2093 | author name string | During MJ | |
| Xu R | |||
| Baer K | |||
| Fitzsimons H | |||
| Mastakov MY | |||
| P433 | issue | 2 | |
| P921 | main subject | D-(-)-mannitol | Q407646 |
| P304 | page(s) | 225-232 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Combined injection of rAAV with mannitol enhances gene expression in the rat brain | |
| P478 | volume | 3 |
| Q39285528 | A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles. |
| Q38075068 | A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting. |
| Q35114530 | AAV-mediated overexpression of neuroserpin in the hippocampus decreases PSD-95 expression but does not affect hippocampal-dependent learning and memory. |
| Q92069614 | Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation |
| Q34987171 | Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. |
| Q39266351 | An Immunological Approach to Increase the Brain's Resilience to Insults. |
| Q93051143 | Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain |
| Q36823757 | Diffusion of macromolecules in the brain: implications for drug delivery |
| Q44109104 | Effect of hyperosmolar mannitol on convection-enhanced delivery into the rat brain stem |
| Q33713108 | Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. |
| Q44918948 | Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. |
| Q42170296 | Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector. |
| Q43092239 | Functional mapping of brain synapses by the enriching activity-marker SynaptoZip. |
| Q37423115 | Functional specialization of mouse higher visual cortical areas. |
| Q91734216 | Gene Therapy for Neurologic Disease: A Neurosurgical Review |
| Q34055904 | Gene transfer to the CNS using recombinant adeno-associated virus |
| Q48150837 | Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. |
| Q48347605 | Hyperosmotic polydixylitol for crossing the blood brain barrier and efficient nucleic acid delivery |
| Q35000819 | Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain |
| Q37041266 | Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter. |
| Q42518623 | Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain |
| Q45870327 | Intracisternal rSV40 administration provides effective pan-CNS transgene expression |
| Q45026873 | Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis. |
| Q40345116 | Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists. |
| Q35040863 | Oncolytic adenoviruses for treatment of brain tumours |
| Q33836915 | Optical recording of neuronal activity with a genetically-encoded calcium indicator in anesthetized and freely moving mice |
| Q42575413 | Production and titering of recombinant adeno-associated viral vectors |
| Q34987192 | Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain |
| Q45871733 | Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors |
| Q45864411 | Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain |
| Q36368045 | Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. |
| Q34987182 | Recombinant adeno-associated virus vector design and gene expression in the mammalian brain |
| Q48327244 | Reorganization of cortical population activity imaged throughout long-term sensory deprivation |
| Q44719583 | Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. |
| Q36408195 | Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior. |
| Q30543904 | Role of motor cortex NMDA receptors in learning-dependent synaptic plasticity of behaving mice |
| Q35073006 | Selective injection system into hippocampus CA1 via monitored theta oscillation |
| Q48218703 | Stereotaxic gene delivery in the rodent brain |
| Q38663895 | Strategies to enhance the distribution of nanotherapeutics in the brain |
| Q28583854 | Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia |
| Q45236560 | Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion |
| Q37313963 | The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain |
| Q37374140 | The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus. |
| Q36448393 | Treatment of human disease by adeno-associated viral gene transfer |
| Q37747148 | Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice |
| Q44576921 | Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. |
Search more.